会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Biologically active thymones from the thymus
    • 来自胸腺的生物活性胸腺
    • US4374828A
    • 1983-02-22
    • US199997
    • 1980-11-17
    • Karl FolkersTeresa M. KubiakHenryk M. StepienNaoki Sakura
    • Karl FolkersTeresa M. KubiakHenryk M. StepienNaoki Sakura
    • A61K35/26A61K37/00
    • A61K35/26Y10S530/837Y10S930/18
    • A class of three substances has been isolated in highly purified form and in substantially pure form by utilizing thymus tissue as a source material. These three substances are designated thymone A, thymone B and thymone C. Thymones A and B are new peptides which yield approximately 13 and 14 individual amino acid moieties, respectively, on acid hydrolysis. Thymones A and B are chemically characterized by electrophoretic and chromatographic values which are appropriate for substances which are substantially pure. Thymone C was highly purified and its biological activity was reproducibly detected and measured. Thymones A, B and C stimulate the proliferation of lymphocytes. Thymone A stimulates the formation of cyclic adenosine monophosphate. Thymone B stimulates the formation of cyclic guanosine monophosphate.The biological activities of these thymones to stimulate the proliferation of lymphocytes and the formations of cyclic nucleotides are basic hormonal functions for the therapeutic enhancement of the immune system in patients who have immune deficiencies from diverse causes.
    • 通过利用胸腺组织作为源材料,已经以高度纯化的形式和基本上纯的形式分离了一类三种物质。 这三种物质被称为胸腺嘧啶A,胸腺嘧啶B和胸腺素C.胸腺嘧啶A和B是分别在酸水解上产生大约13和14个单个氨基酸部分的新肽。 百里香酮A和B的化学特征在于电泳和色谱值,其适用于基本上纯的物质。 胸腺C高度纯化,其生物学活性被重复检测和测定。 胸腺素A,B和C刺激淋巴细胞的增殖。 Thymone A刺激环磷酸腺苷的形成。 胸腺B刺激环磷酸鸟苷的形成。 刺激淋巴细胞增殖和循环核苷酸形成的这些胸腺嘧啶的生物活性是用于治疗增强免疫系统的基础激素功能,其具有不同原因的免疫缺陷。
    • 7. 发明授权
    • Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
    • 果蝇G蛋白偶联受体,核酸和与之相关的方法
    • US07364866B2
    • 2008-04-29
    • US10213821
    • 2002-08-06
    • David E. LoweryValdin G. SmithTeresa M. KubiakMartha J. Larsen
    • David E. LoweryValdin G. SmithTeresa M. KubiakMartha J. Larsen
    • G01N33/53C12N5/06C12N5/00C07K1/00C07K5/00
    • C07K14/705C12N2799/021
    • The present invention provides Drosophila melanogaster GPCR (DmGPCR) polypeptides and polynucleotides which identify and encode such a DmGPCR. In addition, the invention provides expression vectors, host cells, and methods for its production. The invention also provides methods for the identification of homologs in other species and of DmGPCR agonists/antagonists useful as potential insecticides. The invention further provides methods for binding a DmGPCR, methods for identifying modulators of DmGPCR expression and activity, methods for controlling a population of insects with a DmGPCR antibody, a DmGPCR antisense polynucleotide, a DmGPCR binding partner or modulator, and methods of preventing or treating a disease or condition associated with an ectoparasite. Specifically, this invention discloses the matching of the orphan Drosophila drotachykinin, droleucokinin, and drostatin-C receptors with their cognate peptide ligands.
    • 本发明提供了果蝇黑腹果蝇GPCR(DmGPCR)多肽和鉴定和编码这种DmGPCR的多核苷酸。 此外,本发明提供表达载体,宿主细胞及其生产方法。 本发明还提供了用于鉴定其他物种中的同源物的方法和用作潜在杀虫剂的DmGPCR激动剂/拮抗剂。 本发明还提供了用于结合DmGPCR的方法,用于鉴定DmGPCR表达和活性的调节剂的方法,用DmGPCR抗体,DmGPCR反义多核苷酸,DmGPCR结合配偶体或调节剂控制昆虫群体的方法,以及预防或治疗方法 与外寄生物相关的疾病或病症。 具体地说,本发明公开了孤儿果蝇的洛匹心碱,泪果状蛋白和抑制素-C受体与其同源肽配体的匹配。